Welcome, Clinical Rationale of Bioadaptive PCI
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker's Bureau - Sino Medical Sciences Techologies; Orchestra Biomed Inc; Shockwave; Elixir Medical Corp; CeleCor; Foldax; JC Medical Inc.
- Equity/Stock(s)/Options - Ablative Solutions, Inc
- Industry-Funded Research - Edwards Lifesciences